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Experimental dialysis disequilibrium syndrome: Prevention with
glycerol. Patients with renal failure being treated with hemo-
dialysis may develop a clinical syndrome characterized by head-
ache, restlessness, nausea, and emesis, which may progress to
seizures and coma. An experimental model of this syndrome,
called dialysis disequilibrium syndrome (DDS), can be induced
by rapid hemodialysis of uremic dogs (BUN, 200 mgldl; creati-
nine, 11 mg/dl). In the experimental model, dogs treated with
rapid dialysis developed a brain-to-plasma osmotic gradient
which resulted in cerebral edema. There was also a fall in both
pH of cerebrospinal fluid (CSF) and intracellular pH (pH1) of ce-
rebral cortex and an abnormal electroencephalogram (EEG).
The cerebral edema was characterized by an increased osmole
content in cerebral cortex tissue. The increased osmole content
was not related to retention in brain of sodium, potassium, chlo-
ride, urea, or lactate, but was due to undetermined solute (idio-
genic osmoles). When dialysis was modified by the addition of
mannitol to the dialysate (plasma mannitol, 26 mM), brain edema
did not occur, and the fall in brain pH1 was prevented. The EEG,
however, remained abnormal, and the pH of CSF fell. When
dialysis was modified by adding glycerol to the dialysate (plasma
glycerol, 26 mM), brain edema did not occur, brain pH1 and the
pH of CSF were normal, and the EEG improved towards nor-
mal. After dialysis with either mannitol or glycerol in the dialy-
sate, idiogenic osmoles were not present in the brain. Eliminat-
ing the fall in brain pH1 appeared to prevent the formation of
idiogenic osmoles by cerebral cortex. Thus, DDS was partially
prevented by mannitol added to the dialysate. Glycerol, how-
ever, not only prevented all the manifestation of DDS but also
restored the EEG to a normal pattern. Glycerol may be a useful
agent for prevention of dialysis disequilibrium in man.
Prevention par le glycerol du syndrome de dCséquilibre de Ia
dialyse. Les malades atteints d'insuffisance rCnale traitCs par
hémodialyse peuvent développer un syndrome clinique caractér-
isé par une cephalee, une agitation, des nausées et des vomisse-
ments, et qui pelt évoluer vers des crises convulsives et un
coma. Ce syndrome a Cté appelC syndrome de dCsequilibre de Ia
dialyse (DDS) et un modèle experimental peut étre réalisé par
l'hémodialyse rapide de chiens urémiques (azote ureique, 200
mg/dl; crCatinine, 11 mg/dl). Dans cc modéle experimental les
chiens traités par une dialyse rapide développent un gradient de
pression osmotique entre le cerveau et le plasma, qui a pour con-
sequence un oedème cérébral. En même temps, les pH du liquide
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céphalorachidien et du cortex cérébral diminuent et des anoma-
lies électroencéphalographiques apparaissent. L'oedème cCré-
bral est caractérisC par une augmentation du contenu osmolaire
du cortex cérCbral. L'augmentation du contenu osmolaire n'est
pas liée a Ia retention de Na, K, C1, d'urée ou de lactate mais
est dOe a des substances dissoutes indeterminées. L'addition de
mannitol au liquide de dialyse (concentration plasmatique de
mannitol, 26 mM) empéche l'apparition de l'oedCme cérébral et
Ia chute du pH intracellulaire cérébral. Cependant I'EEG reste
perturbé et Ic pH du liquid céphalorachidien diminue. L'addition
de glycerol au dialysat (glycerol plasmatique, 26 mM) évite
l'apparition de l'oedCme cerebral et des modifications des pH et
determine une amelioration de I'EGG. Après les dialyses avec
du mannitol ou du glycerol les substances dissoutes in-
determinees ne sont plus trouvees dans Ic cerveau. Le fait
d'empécher Ia chute du pH cérébral semble éviter Ia formation
de telles substances. Ainsi Ic syndrome de desequilibre est pre-
venu par l'addition de mannitol au dialysat. Le glycerol, cepen-
dant, non seulement empCche les manifestations de cc syndrome
mais ramène I'EEG a une configuration normale. Le glycerol
peut Ctre un agent utile pour Ia prevention du syndrome de des-
équilibre chez l'homme.
A complication of treatment with hemodialysis is
dialysis disequilibrium syndrome (DDS) [1, 21,
which may be characterized only by mild neurologi-
cal manifestations (headache, restlessness, nausea,
emesis), but can progress to seizures and coma.
Characteristic alterations in the electroencephalo-
gram (EEG) are also reported [3, 4]. The syndrome
is most commonly observed either in patients with
acute renal failure who are being treated with their
first few hemodialyses or in children [4, 5]. Symp-
toms of DDS, however, may occur in any azotemic
patient, presumably as a consequence of overly
rapid correction of biochemical abnormalities. We
have previously described an experimental model
of DDS in the acutely uremic dog treated with rapid
hemodialysis [6]. The syndrome in dogs is charac-
terized by grand mal seizures in the unanesthetized
state [6]. Biochemically, there is cerebral edema
which is primarily intracellular. The cerebral edema
appears to be due to an osmotic gradient induced
Glycerol and dialysis disequilibrium syndrome 271
from brain to plasma, which leads to a net move-
ment of water into the brain [6, 7]. The osmotic gra-
dient is not related to retention or accumulation in
brain of any commonly measured solutes—sodium,
potassium, chloride, calcium, magnesium, urea, or
lactate [6, 8]. The cerebral edema is accompanied
by a fall in both the pH of cerebrospinal fluid (CSF)
and the intracellular pH (pH1) of brain tissue (cere-
bral cortex) [8].
Glycerol, a low molecular weight alcohol (92 mg/
mmole), has been used to treat brain edema associ-
ated with many different causes, such as acute cere-
bral infarction and cerebral neoplasm [9—11]. We
have shown that in animals, glycerol can be an ef-
fective cerebral dehydrating agent in both normal
brain and brain with experimental cerebral edema
(cold lesion) [12, 13]. Most of the glycerol is metab-
olized to glucose, water, and carbon dioxide [14—
16]. Since its half-life is less than 3 1/2 hr [12], glyce-
rol's accumulation in the body should cause few un-
toward effects, as may occur with mannitol or other
nonmetabolizable solutes. Based on favorable re-
ports of the clinical efficacy of glycerol in several
clinical conditions felt to be associated with in-
creased intracranial pressure [10, 15—17], it was de-
cided to evaluate this agent in treatment of DDS. To
separate the effects of glycerol from those of hype r-
osmolality itself, effects of mannitol on DDS were
also evaluated.
Methods
Studies were carried out on six groups (total num-
ber of animals, 45) of mongrel dogs of both sexes
(weight, 16 to 23 kg). The groups were as follows:
eight normal dogs (group 1), nine dogs with acute
renal failure for 3.5 days (group 2), six dogs with
acute renal failure treated with rapid hemodialysis
(group 3), eight dogs with acute renal failure treated
with rapid hemodialysis where the dialysate was
modified by the addition of 35 to 85 mi mannitol
(group 4), eight dogs with acute renal failure where
the dialysate was modified by the addition of 50 to
100 mM glycerol (group 5), and six dogs treated
identically to group 5, but after hemodialysis had
been completed (110 mm), these animals were ob-
served for an additional 4 hr and then sacrificed
(group 6). Acute renal failure was induced in
groups 2 through 6 by bilateral ureteral ligation [6].
Electroencephalograms (EEG) were done in all
animals. In the animals treated with hemodialysis
(groups 3 through 6), EEG's were done prior to dial-
ysis and at 30-mm intervals until the conclusion of
the experiment. The EEG's were standard eight-
channel recordings and were obtained with a elec-
troencephalograph (Beckman Accutrace, Beckman
Instruments, Inc., Mountain View, Calif.) with
eight subcutaneous needle electrodes [18]. The trac-
ings were analyzed for frequency distribution and
power spectrum, as previously described [18].
The intracellular pH (pH1) and extracellular space
(ECS) were determined in brain tissue (cerebral
cortex) and subcortical white matter of all animals.
The ECS was evaluated by determining the distri-
bution of radioactive sulfate' in cerebral cortex tis-
sue relative to cortical cerebrospinal fluid (CSF).
The pH1 of cerebral cortex tissue was determined
by the distribution of 14C-dimethadione (DMO)a in
brain relative to cortical CSF, with the extracellular
pH measured in cisternal CSF. The complete ana-
lytical methods have been described from this labo-
ratory [19]. In all animals, the pH, Po2, Pco2, and
bicarbonate concentration were measured in arteri-
al blood and cisternal CSF [6]. In animals treated
with hemodialysis, arterial blood gases were mea-
sured every 30 mm. CSF gases were obtained only
twice, at the start and finish of each experiment.
In both cerebral cortex and subcortical white
matter of the brain, measurements were made of
water content and the concentrations of sodium,
potassium, calcium, magnesium, and chloride. Wa-
ter content was determined by over-drying at
105° C to constant weight. The tissues were then
extracted for 24 hr in 750 ifiM nitric acid; and sodi-
um, potassium, chloride, calcium, and magnesium
concentrations were determined in the supernatant.
Complete analytical methods have been described
[6, 20]. The brain osmolality was measured in a
sample of frontal hemisphere that had been rapidly
(less than 8 sec) frozen in liquid nitrogen [21].
Glycerol or mannitol were measured in both corti-
cal gray matter and subcortical white matter, as well
as in plasma and CSF, of groups 4 through 6. The
samples were extracted in 0.5 N perchloric acid and
2.0 N potassium hydroxide [12], and glycerol or
mannitol were determined in the supernatants [12,
22].
Additionally, in both plasma and CSF, measure-
ments were made of osmolality and the concentra-
tions of urea, creatinine, sodium, potassium, chlo-
ride, calcium, and magnesium [6, 20].
Rapid hemodialysis was carried out with a hemo-
dialysis machine (Travenol RSP) and pediatric coil
(0.6m2) at a blood flow of 12 mI/kg and a dialysate
All isotopes were obtained from New England Nuclear, Bos-
ton, Mass.
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flow of 500 mI/mm for a duration of 110 mm [6].
Such a dialysis protocol results in a mean fall of
plasma creatinine and urea nitrogen by 7 mg/dl (0.62
mmole/liter) and 123 mg/dI (44 mmoles/liter), re-
spectively [6]. These procedures resulted in urea
and creatinine clearances of 66.5 mI/mm and 63.1
mi/mm, respectively (assuming that both urea and
creatinine are distributed throughout total body wa-
ter). In group 3, standard dialysate (Diasol, Tray-
enol Laboratories, Deerfield, Ill.) was used. In
groups 4 through 6, glycerol or mannitol was added
to the dialysate in quantities such that for the dura-
tion of hemodialysis, osmolality of the animal did
not change. Based on preliminary experiments in
group 5 and 6 animals, glycerol was added to the
dialysate such that dialysate osmolality exceeded
that of plasma by 15 mOsm/kg of water. With this
amount of glycerol, plasma osmolality did not
change during dialysis. For group-4 dogs, mannitol
was added to the dialysate such that the os-
molalities of plasma and dialysate were the same.
The net result of dialysis with these modified dialy-
sates was the infusion of either glycerol (groups 5
and 6) or mannitol (group 4) as urea was removed
by hemodialysis.
Prior to hemodialysis, animals were sedated with
a single i.m. dose of xylazine, 2 mg/kg of body wt
(Rompun, Cutter Labs, Shawnee, Kansas), and
then paralyzed with 1 mg/kg/hr of i.v. succinyicho-
line (Anectine, Burroughs Welcome & Co., Re-
search Triangle Park, N.C.). The animals were im-
mediately intubated and mechanically ventilated [6,
19]. The arterial Pco2 was adjusted to about 35 mm
Hg, and ventilation was then maintained constant
throughout the experiment. EEG's were done be-
fore, during, and after hemodialysis, as previously
described [18]. Prior to killing all animals, we
anesthetized them with sodium pentobarbitol (12 to
16 mg/kg i.v.). EEG's were not done after adminis-
tration of barbiturate [181.
All values are given as the mean SEM. Statisti-
cal differences were calculated by Student's t test of
group means.
Results
Effects of hemodialysis on blood and CSF. In
nine animals with acute renal failure for 3.5 days,
the plasma urea nitrogen and creatinine (± SEM)
were 71 6 mmoles/liter (199 17 mgldl) and 1.02
0.03 mmoles/liter (11.5 0.3 mg/dl), respective-
ly. (For plasma urea nitrogen, 1 mmoie/liter = 2.8
mg/dl, and for serum creatinine, I mmole/liter =
11.3 mg/dl.) The plasma osmolality was 341 4
mOsm/kg of water, and osmolality in CSF was 342
4 mOsm/kg of water. Glycerol was less than 1
mmole/liter in both CSF and plasma.
After rapid hemodialysis, the plasma osmolality
was 300 2 mOsm/kg, and that in CSF was 318 2
mOsm/kg. The decline in plasma osmolality was
primarily due to a fall in plasma urea concentration
to 30 4 mmoles/liter, and creatinine fell to 5.3
0.7 mg/dl.
After rapid hemodialysis with glycerol in the
dialysate (group 5), plasma osmolality was un-
changed at 339 3 mOsm/kg. Plasma urea concen-
tration fell by 41 mmoles/liter, and plasma sodium
concentration, which was 130 4 mmoles/liter in
uremic dogs, was 136 3 mmoles/liter after rapid
dialysis with glycerol. The CSF osmolality was un-
changed at 340 2 mOsm/kg of water, sodium con-
centration in CSF was 145 2 mmoles/liter (pre-
dialysis value, 140 4), and CSF urea concentra-
tion was 49.4 4.0 mmoles/liter (predialysis value,
63.1 4.1). Thus, the net effect of hemodialysis
with glycerol was a loss of urea with replacement by
both glycerol and sodium, with 65% of the urea lost
from plasma being replaced by glycerol. Four hours
after completion of dialysis, plasma osmolality
(group 6) was 330 7 mOsm/kg, and sodium con-
centration was 142 4 mmoles/liter.
After rapid dialysis with mannitol in the dialysate
(group 4), plasma osmolality was 342 4 mOsm/kg,
vs. a predialysis value of 341 6. The plasma so-
dium concentration was 133 2 mmoles/liter, and
plasma urea concentration was 44.9 3.7 mmoles/
liter (predialysis value, 91.1 5.6). In CSF, os-
molality was 337 4 mOsm/liter, vs. a predialysis
value of 345 6, and sodium concentration was 140
4 mmoles/liter.
Mannitol and glycerol concentrations. When
mannitol was added to dialysate (group 4), mannitol
concentrations in plasma and CSF were 25.6 2.6
and 4.4 2.0 mmoles/liter, respectively. In brain
tissue, mannitol was 5.4 0.8 mmoles/kg of water
in gray matter and 3.9 0.4 mmoies/kg of water in
white matter.
After hemodialysis with glycerol (group 5),
plasma glycerol was 26.4 3.6 mmoles/liter, and
that in CSF was 4.1 1 mmoles/liter. Glycerol in
cerebral cortex was 10.0 0.9 mmoles/kg of water,
and that in white matter was 5.2 1.2 mmoles/kg of
water.
Acid-base balance in blood and CSF. In nine
dogs with acute renal failure, arterial pH was 7.22
0.02, Pco2 was 35 3 mm Hg, bicarbonate concen-
tration was 14.2 0.7 mmoles/liter, and Po2 was 78
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4 mm Hg. In CSF, corresponding values were:
pH, 7.31 0.02; Pco2, 41 1 mm Hg; bicarbonate
concentration, 21.4 1.1 mmoles/liter; and Po2, 58
3 mm Hg.
After rapid hemodialysis, the arterial Pco2 and
Po2 were unchanged, the pH rose to 7.32 0.01,
and bicarbonate concentration rose to 17.7 0.9
mmoles/liter. In CSF, however, there was a fall in
both pH and bicarbonate, despite the rise of these
values in arterial blood. The pH in CSF was 7.21
0.02, and bicarbonate concentration was 15.4 0.5
mmoles/liter (P < 0.01).
When mannitol was added to the dialysate (group
4), the arterial blood gases were again not different
from values observed after hemodialysis with stan-
dard dialysate. Arterial pH was 7.32 0.03, and
bicarbonate was 18.9 1.5 mmoles/liter. The de-
cline in pH of CSF, however was only partially pre-
vented by addition of mannitol to the dialysate. Af-
ter dialysis with mannitol, pH of CSF was 7.31
0.02 (pre-dialysis value, 7.36 0.02, P < 0.01), and
bicarbonate concentration in CSF was 18.1 0.6
mmoles/liter (predialysis value, 21.4 3.5, P <
0.05). Thus, although glycerol in dialysates pre-
vented the fall in pH of CSF, mannitol did not.
After rapid dialysis with glycerol (group 5),
changes in arterial blood gases were similar to those
observed after dialysis with standard dialysate. In
CSF, however, the pH was 7.30 0.02 (predialysis
value, 7.29 0.03), and bicarbonate concentration
was 18.5 0.8 mmoles/liter (predialysis value, 18.8
0.6). Thus, addition of glycerol to dialysate pre-
vented the fall in the pH of CSF observed after stan-
dard hemodialysis.
Changes in brain intracellular pH. In uremic
dogs (group 2), the intracellular pH (pH1) of brain
was 7.06 0.02 in gray matter (normal, 7.05 0.01)
and 6.97 0.01 in white matter (normal, 6.98
0.02). After rapid dialysis with standard dialysate
(group 3), the pH1 in cerebral cortex had fallen to
6.89 0.02 (P < 0.01) while that in white matter
was unaltered (7.00 0.06) (Fig. 1). Accompanying
the fall in pH, of cerebral cortex was a 10% increase
in its water content (Fig. 2), without significant
change in brain content of magnesium, potassium,
or chloride (Fig. 3). There was a decrement in cal-
cium and a rise in sodium concentrations (Fig. 3).
After rapid dialysis with mannitol (group 4), the
pH, of cerebral cortex was 7.02 0.04, a value not
significantly different from normal or uremic ani-
mals (P > 0.05 vs. groups 1 and 2) but significantly
greater than observed after rapid dialysis with stan-
dard dialysate (P < 0.01 vs. group 3). The pH1 of
380
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Fig. 2. Brain tissue (cerebral cortex) water content in four groups
of dogs (groups 2 through 5). After rapid hemodialysis with stan-
dard dialysate (dialysis, group 3), there is a significant (P < 0.01)
increase of brain water content. Cerebral edema is prevented by
addition to dialysate of mannitol or glycerol (groups 4 and 5).
white matter remained in the normal range (7.05
0.04). Thus, addition of mannitol to the dialysate al-
so prevented the fall in brain pH, induced by rapid
hemodialysis (Fig. 1).
Rapid dialysis with glycerol added to dialysate
significantly modified the changes in brain pH1. Af-
ter hemodialysis with glycerol (group 5), the pH, of
cerebral cortex was 7.14 0.01 (P < 0.01 vs. ure-
mic animals treated with rapid hemodialysis, Fig.
1), although that in white matter was unaltered (7.00
0.03). The cerebral cortex pH, was essentially
unchanged 4 hr after dialysis (7.15 0.02), as
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Fig. 1. Brain tissue (cerebral cortex) intracellular pH (pH1) in
uremic dogs and dogs treated with rapid hemodialysis (dialysis).
There is a significant decrement (P < 0.01) in brain pH following
conventional dialysis. The brain pH1 is normal after dialysis with
addition of either glycerol or mannitol to the dialysate.
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Fig. 3. Brain tissue (cerebral cortex) content of potassium, so-
dium, calcium, and magnesium in five groups of dogs. Brain cal-
cium concentration is significantly elevated (P < 0.01) in uremic
animals and is restored to normal by dialysis (groups 3 through
5). Brain sodium concentration is significantly decreased in ure-
mic dogs (group 2) and is restored to normal by dialysis (group 3)
or dialysis with glycerol (group 5), but not with mannitol (group
4). Brain magnesium and potassium concentrations are unaf-
fected by uremia or dialysis.
was that in white matter (7.01 0.04). Thus, dial-
ysis with glycerol prevented the fall in brain pH1 ob-
served after rapid dialysis (Fig. 1).
Brain osmolality. In uremic dogs, the brain os-
molality was 342 10 mOsm/kg of water (normal,
305 5). After hemodialysis with mannitol in the
dialysate (group 4), brain osmolality was 334 7
mOsmlkg of water, which was also similar to values
observed in plasma (342 4 mOsmlkg) and CSF
(335 4 mOsmlkg). After hemodialysis with glyc-
erol (group 5), brain osmolality was 335 8 mOsm/
kg of water, a value not different from osmolalities
of plasma (339 4 mOsmlkg) or CSF (340 2
mOsmlkg). Four hours after cessation of dialysis
(group 6), brain osmolality was 326 6 mOsmlkg of
water.
The brain osmole content after hemodialysis with
glycerol was 1,350 29 mOsm/kg of dry wt (nor-
mal, 1242 34), a value not different from that ob-
served after rapid hemodialysis with mannitol (1336
31 mOsmlkg of dry wt) or in uremic animals not
treated with hemodialysis (1371 20 mOsmlkg of
dry wt). After rapid hemodialysis with standard
dialysate (group 3), however, the brain osmole
content was 1,444 27 mOsm/kg of dry wt, a value
significantly higher (P < 0.05) than that observed
after dialysis with either glycerol or mannitol added
to the dialysate (groups 4 and 5). The difference in
osmole content between groups 4 and 5, vs. group
2, presumably represents idiogenic osmole forma-
tion by the brain. Thus, rapid dialysis with either
glycerol or mannitol in the dialysate prevented the
formation of idiogenic osmoles by the brain.
EEG changes. In dogs with acute renal failure
(group 2), the EEG was grossly abnormal, as shown
in Figures 4 and 5. The percent EEG power < 5 Hz
....—4Na was 44 5%, vs. the normal value of 4.4 1.4% (P
<0.01). The percent of frequencies > 9 Hz (normal
frequencies) was only 10 3% (normal, 57 7%, P
<0.01), although frequencies < 7 Hz (generally ab-
normal frequencies) were 66 4% (normal, 17
4%, P < 0.01).
Both during and after rapid hemodialysis (group
3), there was no significant alteration in any of the
aforementioned EEG measurements (Figs. 4 and 5).
Similarly, during and after rapid hemodialysis with
mannitol (group 4), there was also no significant al-
teration in either the percent of EEG power < 5 Hz,
or the frequency distribution above 9 Hz or below 7
Hz (Figs. 4 and 5).
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Fig. 4. The percent of EEG power < 5Hzas a useful indicator of
the severity of metabolic brain disease. It is abnormal in uremic
dogs (group 2) and is unaffected by dialysis (group 3) or dialysis
with mannitol (group 4). It is restored to normal values, how-
ever, after dialysis with glycerol (group 5).
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Fig. 5. The distribution offrequencies below 7Hz (abnormal) and
above 9 Hz (normal). The EEG is grossly abnormal in uremic
dogs (group 2) and is unaffected by dialysis or dialysis with man-
nitol (groups 3 and 4). After dialysis with glycerol (group 5), the
frequency distribution is not different from normal values.
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There were significant shifts in the EEG after rap-
id dialysis with glycerol. The percent of EEG power
<5 Hz was 8.6 2.2%, a value not different from
normal (Fig. 4). Both the percent of EEG frequen-
cies below 7 Hz (27 6) and above 9 Hz (39 6)
improved (Fig. 5), and were not significantly dif-
ferent (P > 0.05) from normal values. Four hours
after rapid dialysis with glycerol, the percent of
EEG power < 5 Hz (10.4 2.4%) and the percent
of EEG frequencies below 7 Hz (33 8%) were not
different from normal values (P > 0.05). The per-
cent of EEG frequencies > 9 Hz (31 8%) were
significantly (P < 0.05) below normal. Thus, rapid
dialysis with glycerol in the dialysate improved the
EEG almost to normal, and most of these changes
persisted for at least 4 hr after the termination of
dialysis.
Brain water and electrolytes. After rapid dialysis
of uremic dogs, there were significant increases of
brain tissue water content in both white and gray
matter (Fig. 2). The water content in white matter
was 237 12 g/lOO g of dry wt (uremia, 211 6),
and that in gray matter was 460 11 gIlOO g of dry
wt (uremia, 397 7). After rapid dialysis with
glycerol (group 5), however, brain water was nor-
mal in both white (208 9 gIlOOg of dry wt) and
gray (402 10 g/100 g of dry wt) matter (Fig. 2).
Four hours after termination of dialysis (group 6),
brain water content remained within the normal
range of both gray (417 6 g/lOO g of dry wt) and
white (195 2 g/lOO g of dry wt) matter. After rapid
dialysis with mannitol (group 4), brain water con-
tent was also normal in both white (205 3 g/100 g
of dry wt) and gray (406 9 g/ 100 g of dry wt) mat-
ter (Fig. 2). Thus, rapid dialysis with either glycerol
or mannitol added to the dialy sate prevented the de-
velopment of brain edema.
In animals with acute renal failure (group 2),
there was a significant decrease in brain tissue (ce-
rebral cortex) content of sodium (Fig. 3). After dial-
ysis with either standard dialysate or glycerol
(groups 3 and 5), brain sodium concentration in-
creased to normal values (Fig. 3). Brain potassium
and magnesium content were essentially unaltered
by either uremia or dialysis (Fig. 3). Cerebral cortex
calcium concentration was 19.6 1.1 mEq/kg of
dry wt in uremic animals (normal value, 13.2 0.5,
P < 0.01). After dialysis (groups 3), brain calcium
concentration decreased towards normal to 15.2
0.8 mEq/kg of dry wt. After dialysis with glycerol or
mannitol (groups 4 and 5), cerebral cortex calcium
concentration content also decreased to 14.2 0.7
and 15.4 0.8 mEq!kg of dry wt, respectively (Fig.
3).
Discussion
These experiments demonstrate that in acutely
uremic dogs treated with hemodialysis, experimen-
tal dialysis disequilibrium syndrome can be pre-
vented by addition of glycerol to the dialysate. Ad-
ditionally, many of the manifestations of experi-
mental DDS are also prevented by addition of
mannitol to dialysate.
The manifestations of experimental DDS consist
of brain edema due to an osmotic gradient from
brain to plasma [6, 7], with a fall in pH of CSF and
pH1 in cerebral cortex [8] and an abnormal EEG
[3, 4, 23, 24]. The elevated brain osmolality is not
due to retention in brain of commonly measured so-
lutes, such as sodium, potassium, chloride, cal-
cium, magnesium, urea, or lactate [6—8], but appears
rather to be due to the de novo generation in brain
of unidentified solutes—idiogenic osmoles [6, 8].
Production of the idiogenic osmoles appears to be
related to the fall in pH of CSF and cerebral cortex
pH1 [8]. In the present experimental model of DDS,
these pH decrements occurred even though animals
were mechanically ventilated, with arterial Pco2
maintained constant throughout the experiment.
Another group where there is an apparent pH dis-
equilibrium between CSF and arterial blood is pa-
tients with diabetic ketoacidosis who are rapidly
given i.v. sodium bicarbonate. In this situation,
there is apparent hypoventilation, with a rise in ar-
terial Pco2, diffusion of carbon dioxide into the
CSF, and a resultant fall in pH of CSF [25—27]. The
situation is apparently different, however, in pa-
tients with renal failure. Here, plasma bicarbonate
concentration is rapidly elevated by infusion
(across the dialysis membrane) of acetate, with sub-
sequent conversion to bicarbonate. Studies of acid-
base status in uremic subjects treated with hemo-
dialysis, however, suggest that despite acute eleva-
tion of plasma bicarbonate concentration, hypoven-
tilation is not generally observed [23, 281. In animal
studies reported here and elsewhere [6, 8], brain
pH1 and pH of CSF fall during hemodialysis al-
though arterial Pco2 is unaltered. It appears that
both the fall in brain pH1, as well as the pathogene-
sis of DDS, are unrelated to changes in arterial
Pco2.
It has also been observed that at the start of a
high efficiency hemodialysis, there may be an initial
rapid removal of bicarbonate via the dialysis mem-
brane, with delayed conversion of acetate to bi-
carbonate resulting in a transitory worsening of
metabolic acidosis [29]. Such rapid alterations in ar-
terial pH may result in systemic manifestations sim-
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ilar to DDS. The symptoms may be partially alle-
viated by substitution of bicarbonate for acetate in
the dialysate. The systemic effects of high efficien-
cy dialysis with acetate may actually be due to ace-
tate intolerance in selected patients. In general,
acute metabolic alterations of blood pH do not af-
fect brain intracellular pH [30]. Also, a sudden fall
in plasma bicarbonate concentration during dialysis
was not observed in the present experiments. This
may reflect either relatively infrequent sampling of
arterial blood (each 30 mm) or more efficient metab-
olism of acetate in the dog. Thus, the observed ef-
fects of rapid dialysis on brain pH1 in the present
studies appear to be separate from any changes in
arterial pH. Both glycerol and mannitol added to
the dialysate prevent the fall in brain pH1 (Fig. 1),
and as a result, idiogenic osmoles are not present in
the brain of animals so treated.
After rapid dialysis with glycerol, intracellular
pH of brain is slightly alkalotic (Fig. 1). Intracellular
alkalosis has previously been noted in association
with hyperosmolality [31]. Although the exact
mechanism is unclear, intracellular alkalosis may be
associated with an acceleration of glycolysis [31].
With increased availability of glycerol, there should
be increased dihydroxyacetone phosphate [32],
with subsequent increased production of lactate.
Each mole of lactate metabolized consumes one
mole of hydrogen ion, thereby generating a mole of
bicarbonate. Both hyperosmolality and glycerol in-
fusion can result in intracellular alkalosis [31, 33],
and both may also be associated with increased lac-
tate production [32, 34] via accelerated glycolysis.
The increased glycolysis may become self-perpetu-
ating, as intracellular alkalosis would then tend to
accelerate activity of many glycolytic enzymes [32].
Since brain metabolic rate is decreased in uremia
[35, 36], acceleration of glycolysis, with increased
utilization of adenosine tnphosphate, also may be
related to the central nervous system effects noted
after dialysis with glycerol, but not with mannitol.
Glycerol has been shown to be an effective cere-
bral dehydrating agent, both in normal animals and
in those with experimental brain edema [12, 13]. In
addition, glycerol has been used extensively in pa-
tients to treat cerebral edema due to numerous
causes [9—11, 15—17]. Although its mode of action
may be largely mediated by its osmotic effects,
glycerol also has been shown to increase cerebral
blood flow [17]. In addition, it has also been sug-
gested that glycerol may somehow act to increase
oxidative phosphorylation in brain [15—17], possibly
by its conversion to alpha-glycerophosphate and
then to dihydroxyacetone phosphate which can en-
ter the Embden-Meyerhof glycolytic pathway. This
assumption, however, has not been validated. That
glycerol may have other than an osmotic effect on
brain is suggested by comparing its effects on brain
to that of other osmotically active agents. When
added to dialysate during rapid dialysis of uremic
dogs, either sodium chloride, urea, or mannitol will
prevent brain edema [6] (Fig. 2). Only glycerol,
however, prevents the fall in pH of CSF and im-
proves the EEG (Figs. 1, 4, and 5).
We find (Figs. 4 and 5) that there is no change in
the EEG after rapid hemodialysis with standard
dialysate. These results may initially appear to be in
conflict with results from other studies where the
EEG is reported to deteriorate following dialysis
with standard dialysate [3, 4, 23, 24]. Evaluation of
these reports shows that in no instance was a sys-
tematic evaluation of the EEG performed. Rather,
short segments of the EEG are shown, and there are
no standardized criteria used for evaluating or
quantitating deterioration of the EEG. Even under
such circumstances "deterioration" of the EEG is
not seen in all patients [24], and the changes ob-
served are well within the expected range for pa-
tients with renal failure itself, not treated with dial-
ysis [37—39]. There may well be sporadic abnormal
bursts in the EEG during dialysis [4, 23, 40], but the
overall pattern of the tracing is essentially unaltered
(Figs. 4 and 5). It should be pointed out, however,
that our evaluation of the EEG does not take into
account possible effects on visually evoked cortical
potentials [41], discriminant analysis [42], or photic
driving [41]. These parameters may become tran-
siently abnormal during dialysis [40].
There are several studies in uremic patients
where effects of various hyperosmolar substances
added to the dialysate are evaluated. Such sub-
stances include urea, glycose, fructose, sodium
chloride, and mannitol [23, 24, 43—49]. All of these
reports are difficult to evaluate, as the factors exam-
ined were generally subjective clinical symptoms,
and different symptoms were studied in different re-
ports. The effects on these symptoms are inconsis-
tent from one report to the next [4]. Additionally,
many of the patients studied had stable chronic re-
nal failure and were being treated with maintenance
hemodialysis. Such patients are highly unlikely to
develop DDS under any circumstances [4]. It does
appear that in uremic patients being treated with he-
modialysis, addition of either sodium chloride or
mannitol to dialysate may partially ameliorate some
of the symptoms associated with DDS [24, 47—49].
Glycerol and dialysis disequilibrium syndrome 277
Because of their tendency to accumulate in the
body between dialysis and the dangers of circula-
tory congestion and hypertension, neither of these
agents, however, would appear to be satisfactory
for routine use, and certainly not on a repetitive
basis.
Glycerol, on the other hand, has a half-life of less
than 3.5 hr in anephric animals [12] and is not toxic
in doses commonly employed [10, 12]. Glycerol
may thus be a suitable agent for prevention of dial-
ysis disequilibrium in man.
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